Monitoring Vision and Health Outcomes in Non-Arteritic Ischemic Optic Neuropathy Patients

Non-Arteritic Ischemic Optic Neuropathy (NAION) is a common condition that causes sudden vision loss in older adults, with no known effective treatment. It can affect both eyes in up to 40% of patients, with a significant risk within the first two years. The Ischemic Optic Neuropathy Decompression Trial (IONDT) aimed to compare the effectiveness of optic nerve decompression surgery (ONDS) with careful observation alone in patients newly diagnosed with NAION. The surgery was believed to restore vision by reducing pressure on the optic nerve. However, the study found that surgery was not better than careful observation and could potentially be harmful. This led to the abandonment of this costly and ineffective surgery for NAION treatment, leaving a lack of treatment options for the condition.